市场调查报告书
商品编码
1467909
2024-2032 年按产品类型(Guglielmi 可拆卸线圈、矩阵线圈)、适应症、应用、最终用户(医院、门诊手术中心、中风中心等)和地区分類的神经血管线圈市场报告Neuroendovascular Coil Market Report by Product Type (Guglielmi Detachable Coils, Matrix Coils), Indication, Application, End User (Hospitals, Ambulatory Surgical Centers, Stroke Centers, and Others), and Region 2024-2032 |
IMARC Group年,全球神经血管内弹簧圈市场规模达9.999亿美元。
神经血管内弹簧圈栓塞是一种微创血管内治疗,用于阻断脑血管中的血流。治疗动脉瘤至关重要,动脉瘤是由血管壁薄弱引起的隆起,它可能因压力升高而破裂并流入大脑。动脉瘤破裂的症状通常包括突然发作的严重头痛、噁心、呕吐、视力模糊或复视、癫痫发作。在神经血管内弹簧圈栓塞中,外科医师用可拆卸的铂金弹簧圈紧紧包裹动脉瘤,以促进血液凝固并降低外壁的压力。神经血管内弹簧圈栓塞在全球范围内变得越来越流行,因为它的成本较低并降低了患者的风险。
神经血管内线圈技术在形状、长度和生物活性方面取得了一些进展。除此之外,颅内支架在改善其部署和输送方面也取得了重大进展。外科医生已开始将颅内支架与线圈技术相结合,以治疗动脉瘤并减少与復发相关的问题。此外,在术后併发症、良好的结果和復健方面,血管内弹簧圈栓塞被认为是比夹闭术更好的手术技术。除此之外,各个市场参与者都在投资引进技术先进的产品。例如,2018 年,强生医疗器材公司旗下的 Cerenovus 推出了 Galaxy G3 Mini 栓塞弹簧圈,该弹簧圈设计为不规则形状,使该装置能够填充脑动脉瘤中的开放空间。
IMARC 集团的最新报告深入洞察了全球神经血管内弹簧圈市场,涵盖了其所有重要方面。内容涵盖从宏观市场概况到微观细节的行业表现、近期趋势、关键市场驱动因素和挑战、SWOT分析、波特五力分析、价值链分析等。 、研究人员、顾问、商业策略家以及所有拥有任何利益或计划以任何方式进军神经血管内线圈市场的人。
The global neuroendovascular coil market size reached US$ 999.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,260.9 Million by 2032, exhibiting a growth rate (CAGR) of 2.5% during 2024-2032.
Neuroendovascular coiling is a minimally invasive endovascular treatment which is performed to block the blood flow in a blood vessel in the brain. It is essential to treat an aneurysm, a bulge caused by weakness in the wall of a blood vessel, which can rupture due to rising pressure and bleed into the brain. The symptoms of a ruptured aneurysm generally include sudden onset of a severe headache, nausea, vomiting, blurred or double vision, and seizure. In neuroendovascular coiling, a surgeon tightly packs the aneurysm with detachable platinum coils that promote blood clotting and reduce pressure on the outer wall. Neuroendovascular coiling is becoming popular across the globe as it incurs less cost and lowers the risk for the patients.
Several advances have been made in the neuroendovascular coil technology in terms of shape, length and bioactivity. Besides this, significant progress has been made in intracranial stents to improve their deployment and delivery. Surgeons have started integrating intracranial stents with the coil technology to treat aneurysms and reduce issues related to recurrence. Moreover, endovascular coiling is being considered a better surgical technique than clipping regarding postoperative complications, favorable outcomes and rehabilitation. Other than this, various market players are investing in the introduction of technologically advanced products. For instance, in 2018, Cerenovus, a division of the Johnson & Johnson Medical Devices Companies, launched the Galaxy G3 Mini embolic coil which is designed to have an irregular shape to enable the device to fill open spaces in cerebral aneurysms.
IMARC Group's latest report provides a deep insight into the global neuroendovascular coil market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the neuroendovascular coil market in any manner.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neuroendovascular coil market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, indication, application, and end user.
Guglielmi Detachable Coils (GDCs)
Matrix Coils
Ruptured Aneurysm
Unruptured Aneurysm
Tumor Surgery
Medical Teaching
Others
Hospitals
Ambulatory Surgical Centers (ASCs)
Stroke Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic, Stryker Corporation, DePuy Synthes, Penumbra, Johnson & Johnson Services Inc., Terumo Corporation, Cardinal Health, Boston Scientific Corporation, Cook Medical Incorporated, Balt Extrusion, EndoShape, etc.